Decision Model of Segmental Compared With Total Abdominal Colectomy for Colon Cancer in Hereditary Nonpolyposis Colorectal Cancer

被引:32
作者
Maeda, Takafumi
Cannom, Rebecca R.
Beart, Robert W., Jr.
Etzioni, David A. [1 ]
机构
[1] Univ So Calif, Keck Sch Med, Dept Surg, Div Colorectal Surg, Los Angeles, CA 90033 USA
关键词
FAMILIAL ADENOMATOUS POLYPOSIS; POUCH-ANAL ANASTOMOSIS; QUALITY-OF-LIFE; ILEORECTAL ANASTOMOSIS; GENERAL-POPULATION; RECTAL-CANCER; SURVIVAL; HNPCC; SURVEILLANCE; MUTATIONS;
D O I
10.1200/JCO.2009.25.9812
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose In choosing the appropriate surgical option for patients with colon cancer and Lynch syndrome, goals of treatment are to maximize life expectancy while preserving quality of life. This study constructs a decision model that encompasses these two related considerations. Methods We constructed a state-transition (Markov) model based on assumptions obtained from available data sources and published literature. Two strategies were considered for the treatment of colon cancer in a patient with Lynch syndrome: segmental colectomy (SEG) and total abdominal colectomy (TAC) with ileorectal anastomosis. Quality-adjusted life years (QALYs) were calculated based on utility states for patients based on the colectomy they received. Multiple sensitivity analyses were planned to examine the impact of each assumption on model results. Results For young (30-year-old) patients with Lynch syndrome, mean survival was slightly better with TAC than with SEG (34.8 v 35.5 years). When QALYs were considered, the two strategies were approximately equivalent, with QALYs per patient of 21.5 for SEG and 21.2 for TAC. With advancing age, SEG becomes a more favorable strategy. Results of our model were most sensitive to the utility state of TAC (relative to SEG), rates of metachronous occurrence, and stage of cancer at the time of such occurrence. Conclusion SEG and TAC are approximately equivalent strategies for patients with colon cancer and Lynch syndrome. The decision regarding which operation is preferable should be made on the basis of patient factors and preferences, with special emphasis on age and the ability of the patient to utilize intensive surveillance. J Clin Oncol 28: 1175-1180. (C) 2010 by American Society of Clinical Oncology
引用
收藏
页码:1175 / 1180
页数:6
相关论文
共 44 条
[1]   Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease [J].
Aaltonen, LA ;
Salovaara, R ;
Kristo, P ;
Canzian, F ;
Hemminki, A ;
Peltomäki, P ;
Chadwick, RB ;
Kääriäinen, H ;
Eskelinen, M ;
Järvinen, H ;
Mecklin, JP ;
de la Chapelle, A ;
Percesepe, A ;
Ahtola, H ;
Härkönen, N ;
Julkunen, R ;
Kangas, E ;
Ojala, S ;
Tulikoura, J ;
ValKamo, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) :1481-1487
[2]   Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis [J].
Aziz, O ;
Athanasiou, T ;
Fazio, VW ;
Nicholls, RJ ;
Darzi, AW ;
Church, J ;
Phillips, RKS ;
Tekkis, PP .
BRITISH JOURNAL OF SURGERY, 2006, 93 (04) :407-417
[3]   Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer [J].
Barnetson, Rebecca A. ;
Tenesa, Albert ;
Farrington, Susan M. ;
Nicholl, Iain D. ;
Cetnarskyj, Roseanne ;
Porteous, Mary E. ;
Campbell, Harry ;
Dunlop, Malcolm G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (26) :2751-2763
[4]   Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations [J].
Barrow, E. ;
Alduaij, W. ;
Robinson, L. ;
Shenton, A. ;
Clancy, T. ;
Lalloo, F. ;
Hill, J. ;
Evans, D. G. .
CLINICAL GENETICS, 2008, 74 (03) :233-242
[5]   Cancer characteristics in Swedish families fulfilling criteria for hereditary nonpolyposis colorectal cancer [J].
Bermejo, JL ;
Eng, C ;
Hemminki, K .
GASTROENTEROLOGY, 2005, 129 (06) :1889-1899
[6]  
Bertario L, 1999, INT J CANCER, V80, P183, DOI 10.1002/(SICI)1097-0215(19990118)80:2<183::AID-IJC4>3.0.CO
[7]  
2-W
[8]   Prophylactic surgery in hereditary cancer syndromes: An ounce of prevention may be the only cure [J].
Bilimoria, MM .
JOURNAL OF SURGICAL ONCOLOGY, 2002, 79 (03) :131-133
[9]  
BOICE JL, 1983, J MED EDUC, V58, P61
[10]  
Cappel WHDTN, 2003, GUT, V52, P1752